SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-284946
Filing Date
2015-08-10
Accepted
2015-08-10 16:31:18
Documents
12
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d33775d10q.htm 10-Q 367984
2 EX-10.1 d33775dex101.htm EX-10.1 50606
3 EX-31.1 d33775dex311.htm EX-31.1 8177
4 EX-31.2 d33775dex312.htm EX-31.2 8160
5 EX-32.1 d33775dex321.htm EX-32.1 4048
12 GRAPHIC g33775g33w26.jpg GRAPHIC 7474
  Complete submission text file 0001193125-15-284946.txt   2536889

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cara-20150630.xml EX-101.INS 352833
7 XBRL TAXONOMY EXTENSION SCHEMA cara-20150630.xsd EX-101.SCH 35367
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cara-20150630_cal.xml EX-101.CAL 46829
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cara-20150630_def.xml EX-101.DEF 105832
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cara-20150630_lab.xml EX-101.LAB 284208
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cara-20150630_pre.xml EX-101.PRE 200202
Mailing Address ONE PARROTT DRIVE SHELTON CT 06484
Business Address ONE PARROTT DRIVE SHELTON CT 06484 203-567-1500
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36279 | Film No.: 151041143
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences